Immediate Impact

3 by Nobel laureates 53 standout
Sub-graph 1 of 22

Citing Papers

Interstitial Lung Disease
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
4 intermediate papers

Works of Akihiro Murakami being referenced

Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
2016
Squamous cell carcinoma antigen suppresses radiation-induced cell death
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Akihiro Murakami 418 149 572 553 52 1.6k
Hua Ye 359 120 128 926 39 1.7k
Signe Holm Nielsen 342 47 256 133 77 1.4k
Tauro Maria Neri 579 509 174 331 50 2.1k
Masahide Kubo 579 241 411 355 66 2.1k
Margarita Indelman 961 16 93 237 40 2.0k
Shuji Sumitomo 377 100 181 389 68 1.6k
Daisuke Kawabata 313 226 616 1011 48 1.8k
Dror Berel 687 36 371 157 53 1.9k
Elizabeth E. Brown 812 245 227 427 65 2.1k
Pilar Lardelli 298 76 332 62 71 1.5k

All Works

Loading papers...

Rankless by CCL
2026